Shares of molecular diagnostics company Exact Sciences Corporation (EXAS) are rising more than 14% Monday morning after reporting fourth-quarter and full-year preliminary revenue, better than analysts' view.
The company expects revenue in the fourth quarter to be between $464.5 million and $467.5 million. Analysts polled by Thomson Reuters expect the company to report revenues of $431.18 million for the quarter.
For the full-year, the company projects revenue to be between $1.490 billion and $1.493 billion. The consensus estimate stands at $1.46 billion.
EXAS touched a new high of $152.48 this morning.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.